Australia, Dec. 17 -- AC Immune SA, owns the trademark (2040388) for 'MORPHOMER' till Sept. 27, 2029.
Status: registered:
Registered/protected
Classes: 1 [Chemicals for use in industry and science; chemical substances, chemical materials and chemical preparations, and natural elements; chemical, biochemical, biological and biotechnological preparations; small molecules; molecular libraries; small molecule library; detectably labelled compound for industrial, scientific purposes; diagnostic reagents for industrial, scientific or research purposes; immunological reagents for industrial, scientific or research purposes; diagnostic tools, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds for industrial, scientific purposes other than for medical or veterinary use; diagnostic reagents for industrial, scientific or research purposes other than for medical or veterinary use; none of the foregoing in relation to and for antibodies], 5 [Pharmaceuticals, medical and veterinary preparations; diagnostic preparations and materials; diagnostic tools, companion diagnostic agents, biomarkers, imaging agents, PET-Imaging compounds; chemical preparations for medical purposes; chemico-pharmaceutical preparation for medical purposes; small molecule compounds for medical purposes; PET-Imaging; companion compound; biomarkers; diagnostic reagents for medical purposes; none of the foregoing in relation to and for antibodies] and 42 [Scientific and technological services and research activities relating thereto; providing access to a proprietary technology platform containing small molecules; chemical research services; medical research services; clinical trials; laboratory services in biotechnology, chemistry, pharmacy, molecular science and immunotherapy; providing medical and scientific research information in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; scientific research, development and consultancy in the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; development of test procedures, assays, test reagents, PET-imaging, companion diagnostic biomarkers, test kits for the field of biotechnology, chemistry, pharmacy, molecular science, immunotherapy, therapeutics, diagnostics and clinical trials; screening and selection of pharmaceutical active substances from biological and biotechnological preparations; Assay development; none of the foregoing in relation to and for antibodies]
Type of Mark: Word
Date of Acceptance: Jan. 7, 2021
Registration Advertised: Dec. 16
For further details contact Davies Collison Cave Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2040388.
Disclaimer: Curated by HT Syndication.
